Join to View Full Profile
11100 Euclid AveCleveland, OH 44106
Phone+1 216-844-0139
Fax+1 212-746-6678
Dr. van Besien is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 1989 - 1990- Indiana University School of MedicineResidency, Internal Medicine, 1987 - 1989
Catholic University of LeuvenClass of 1984
Certifications & Licensure
OH State Medical License 2022 - 2026
NY State Medical License 2011 - 2025
IL State Medical License 1997 - 2014
TX State Medical License 1992 - 2001
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 22 citationsMulticenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL.Jia Ruan, Alison Moskowitz, Neha Mehta-Shah, Lubomir Sokol, Zhengming Chen
Blood. 2023-05-04 - 3 citationsScreening Chest CT Prior to Allogenic Hematopoietic Stem Cell Transplantation.Mohammad Alhomoud, Nora Chokr, Alexandra Gomez-Arteaga, Zhengming Chen, Joanna G Escalon
Transplantation and Cellular Therapy. 2023-05-01 - 9 citationsPre-Hematopoietic Stem Cell Transplantation Rituximab for Epstein-Barr Virus and Post-Lymphoproliferative Disorder Prophylaxis in Alemtuzumab Recipients.Chandni Patel, Michelle Pasciolla, Rachel Abramova, David Salerno, Alexandra Gomez-Arteaga
Transplantation and Cellular Therapy. 2023-02-01
Abstracts/Posters
- Disease Risk Index (DRI) and Age but Not HCT Comorbidity Index (HCT-CI) Are Predictive of Overall Survival after Cord Blood Transplantation Supported By Haplo-CD34+ pr...Koen Van Besien, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Thirty-Day Transfusion and G-CSF Requirement after CD19 CAR T InfusionKoen Van Besien, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Haplo-Cord Transplantation with Anti-Thymocyte Globulin: Comparative Clinical Outcomes with or without Routine G-CSF AdministrationKoen Van Besien, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Hematopoietic Stem Cell Transplant in Novel Agent Era Is Associated with Improved Survival in Relapsed and Refractory Peripheral T-Cell Lymphoma2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Sustained Disease Control for Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: An Updated Analysis of Juliet, a Global Pivotal Phase 2 Trial o...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Does Presence of Persistent Molecular Mutations Matter in AML Patients Undergoing Allogeneic Stem Cell Transplant?2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Other Languages
- Spanish, French, German, Dutch
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
